Blueprint Medicines Corp’s recent filing unveils that its CHIEF FINANCIAL OFFICER Landsittel Michael unloaded Company’s shares for reported $1.05 million on May 02 ’24. In the deal valued at $105.00 per share,10,000 shares were sold. As a result of this transaction, Landsittel Michael now holds 47,286 shares worth roughly $5.02 million.
Then, Hurley Ariel sold 1,834 shares, generating $190,516 in total proceeds. Upon selling the shares at $103.88, the PRINCIPAL ACCOUNTING OFFICER now owns 14,913 shares.
Before that, Landsittel Michael sold 5,000 shares. Blueprint Medicines Corp shares valued at $475,000 were divested by the CHIEF FINANCIAL OFFICER at a price of $95.00 per share. As a result of the transaction, Landsittel Michael now holds 47,286 shares, worth roughly $5.02 million.
Leerink Partners upgraded its Blueprint Medicines Corp [BPMC] rating to a Market perform from a an Underperform in a research note published on May 06, 2024; the price target was increased to $97 from $50. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in late October from “a Perform” to “an Outperform”. Needham also remained covering BPMC and reiterated its “Buy” recommendation on August 21, 2023. Wells Fargo revised its rating on July 31, 2023. It rated BPMC as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of BPMC
On Monday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock fall -0.88% to $106.25. Over the last five days, the stock has gained 14.12%. Blueprint Medicines Corp shares have risen nearly 15.19% since the year began. Nevertheless, the stocks have risen 81.90% over the past one year. While a 52-week high of $110.93 was reached on 05/03/24, a 52-week low of $43.89 was recorded on 02/14/24. SMA at 50 days reached $92.00, while 200 days put it at $71.61. A total of 0.8 million shares were traded, compared to the trading of 2.0 million shares in the previous session.
Levels Of Support And Resistance For BPMC Stock
The 24-hour chart illustrates a support level at 104.99, which if violated will result in even more drops to 103.72. On the upside, there is a resistance level at 108.01. A further resistance level may holdings at 109.77. The Relative Strength Index (RSI) on the 14-day chart is 70.40, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 12.33, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 17.79%. Stochastics %K at 85.29% indicates the stock is a selling.
